CVs for BCR::ABL1IS determination were used to assess how assay variability might correlate with CF status (optimal, satisfactory, or unvalidated) using data for 2019/2020 since this corresponded to the period when the variability data was collected. Here, BCR is linked to cystic fibrosis.